Artemisinin
Showing 1 - 25 of 280
Malaria Trial in Kasese (Artemether/lumefantrine, Ivermectin)
Recruiting
- Malaria
-
Kasese, UgandaST. Paul's Health Center
Oct 31, 2022
Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-lumefantrine and Amodiaquine Drug Combination
- +2 more
-
Bagamoyo, Dar esSalaam, Tanzania
- +1 more
Feb 28, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-Lumefantrine-Amodiaquine (ALAQ)
- +2 more
- (no location specified)
Jul 20, 2023
Acceptability and Costs ofMultiple First-lines Artemisinin-based
Completed
- Malaria
-
Ouagadougou, Burkina FasoGroupe de Recherche Action en Santé
Mar 24, 2022
Covid 19 Positive, Corona Virus Infection Trial in Riyadh (Artemisinin / Artesunate, )
Withdrawn
- Covid 19 Positive
- Corona Virus Infection
- Artemisinin / Artesunate
- placebo
-
Riyadh, Central, Saudi ArabiaPrincess Nourah Bint Abdulrahman Univeristy
Apr 26, 2022
Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg
Not yet recruiting
- Malaria
- +2 more
- Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- Chloroquine plus Tafenoquine (450 mg adult dose)
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Mar 15, 2023
Malaria Trial in Mae Sot (dihydroartemisinin-piperaquine, Artesunate-mefloquine, arthemeter-lumefantrin)
Completed
- Malaria
- dihydroartemisinin-piperaquine
- +2 more
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit
Mar 24, 2022
Covid19, Immunodeficiency Trial in Mecca (Omega 3/Nigella Sativa Oil, Omega 3/Nigella Sativa Oil/Indian Costus, Omega 3/Nigella
Completed
- Covid19
- Immunodeficiency
- Omega 3/Nigella Sativa Oil
- +5 more
-
Mecca, Makkah, Saudi ArabiaMaternity and Children hospital
Jul 18, 2022
Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)
Not yet recruiting
- Vulvar Diseases
- +12 more
- Artesunate ointment
- Placebo ointment
-
Cleveland, Ohio
- +2 more
Oct 4, 2023
COVID-19 Trial in Jardim (OT-101, Artemisinin, Placebo)
Unknown status
- COVID-19
- OT-101
- +2 more
-
Jardim, BrazilPraxis Pesquisa Medica S / S Ltda
Mar 15, 2021
Malaria, Febrile Illness Trial in Lagos (Testing incentive, Conditional artemisinin combination therapy subsidy)
Recruiting
- Malaria
- Febrile Illness
- Testing incentive
- Conditional artemisinin combination therapy subsidy
-
Lagos, NigeriaClinton Health Access Initiative
Feb 4, 2022
Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition, AIN 2/3 Trial in San Francisco, Chicago, New York
Not yet recruiting
- Anal High Grade Squamous Intraepithelial Lesion
- +5 more
- Artesunate
- Placebo
-
San Francisco, California
- +2 more
Nov 7, 2022
Malaria Trial in Goma (ACT, DLA1, DLA2)
Withdrawn
- Malaria
- ACT
- +2 more
-
Goma, N Kivu, Congo, The Democratic Republic of theRwanguba Reference Hospital
Oct 6, 2021
Malaria, Burkina Faso Trial in Ouagadougou (Artemether-lumefantrine)
Not yet recruiting
- Malaria
- Burkina Faso
-
Ouagadougou, Kadiogo, Burkina FasoCentre national de recherche et de formation sur le paludisme (C
Feb 28, 2021
HPV-Related Anal Intraepithelial Neoplasia, AIN2/3, Artesunate Trial in Baltimore, Madison (Artesunate Suppositories)
Completed
- HPV-Related Anal Intraepithelial Neoplasia
- +6 more
- Artesunate Suppositories
-
Baltimore, Maryland
- +1 more
Nov 2, 2021
Plasmodium Falciparum Malaria (Uncomplicated) Trial in Bangladesh, Cambodia, Indonesia (Artemether-lumefantrine+amodiaquine,
Recruiting
- Plasmodium Falciparum Malaria (Uncomplicated)
-
Cox's Bāzār, Chittagong, Bangladesh
- +3 more
Jan 31, 2022
Artemisinin Resistance Through Repeated Cross-sectional
Completed
- Severe Malaria
- Blood sample (combined with malaria RDT) followed by gentoyping analysis
-
Kenge, Kwango, Congo, The Democratic Republic of the
- +6 more
Jan 28, 2021
Plasmodium Falciparum Trial in Kisumu (RTS,S/AS01E, Abhayrab rabies vaccine)
Active, not recruiting
- Plasmodium Falciparum
- RTS,S/AS01E
- Abhayrab rabies vaccine
-
Kisumu, Kisumu County, KenyaKombewa Clinical Research Center
Oct 7, 2021
Polycystic Ovary Syndrome Trial in Shanghai (Dihydroartemisinin)
Active, not recruiting
- Polycystic Ovary Syndrome
-
Shanghai, ChinaZhongshan Hospital Fudan University
Jul 15, 2022
Schistosomiasis Haematobia Trial in Lambaréné (Artesunate-Pyronaridine, Artemether-Lumefantrine, Artefenomel-Ferroquine)
Completed
- Schistosomiasis Haematobia
- Artesunate-Pyronaridine
- +2 more
-
Lambaréné, GabonCentre de Recherches Medicales de Lambarene
Feb 7, 2020
Malaria Trial (5-aminolevulinic acid HCl (5-ALA HCl) 600 mg QD, Sodium ferrous citrate (SFC) 472 mg QD, Artemisinin-based
Withdrawn
- Malaria
- 5-aminolevulinic acid hydrochloride (5-ALA HCl) 600 mg QD
- +5 more
- (no location specified)
Feb 28, 2020
Uncomplicated Plasmodium Falciparum Trial in Tambolaka (Dihydroartemisinin, Piperaquine, Primaquine)
Completed
- Uncomplicated Plasmodium Falciparum
- Dihydroartemisinin
- +3 more
-
Tambolaka, East Nusa Tenggara, IndonesiaKori Puskesmas
Apr 27, 2023
Uncomplicated Falciparum Malaria Trial in Ndola (Artemether-lumefantrine, Dihydroartemisinin-piperaquine)
Active, not recruiting
- Uncomplicated Falciparum Malaria
-
Ndola, Copperbelt, ZambiaTropical Diseases Research Centre
Aug 7, 2020
Plasmodium Falciparum Malaria Trial in Worldwide (malaria elimination using DP and low-dose primaquine)
Completed
- Plasmodium Falciparum Malaria
- malaria elimination using DP and low-dose primaquine
-
Pailin, Cambodia
- +4 more
Aug 26, 2020